Similar articles

• Surgery. β-Blockers--still a trusted ally or time for retirement?

  Vaishnava P, Eagle KA. Vaishnava P, et al. Nat Rev Cardiol. 2014 Sep;11(9):502-3. doi: 10.1038/nrcardio.2014.112. Epub 2014 Jul 29. Nat Rev Cardiol. 2014. PMID: 25072904
• Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis.

  Brinkman W, Herbert MA, O'Brien S, Filardo G, Prince S, Dewey T, Magee M, Ryan W, Mack M. Brinkman W, et al. JAMA Intern Med. 2014 Aug;174(8):1320-7. doi: 10.1001/jamainternmed.2014.2356. JAMA Intern Med. 2014. PMID: 24934977
• Preoperative β-Blockers as a Coronary Surgery Quality Metric: The Lack of Evidence of Efficacy.

  Filardo G, da Graca B, Sass DM, Hamilton J, Pollock BD, Edgerton JR. Filardo G, et al. Ann Thorac Surg. 2020 Apr;109(4):1150-1158. doi: 10.1016/j.athoracsur.2019.07.056. Epub 2019 Sep 9. Ann Thorac Surg. 2020. PMID: 31513778
• [Atrial fibrillation after coronary artery bypass grafting].

  Simonenko VB, Borisov IA, Golikov AP, Dieva TV, Savichev DD. Simonenko VB, et al. Klin Med (Mosk). 2009;87(8):4-6. Klin Med (Mosk). 2009. PMID: 19827521 Review. Russian.
• Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting.

  Kohno H, Koyanagi T, Kasegawa H, Miyazaki M. Kohno H, et al. Ann Thorac Surg. 2005 Jan;79(1):117-26. doi: 10.1016/j.athoracsur.2004.06.062. Ann Thorac Surg. 2005. PMID: 15620927 Review.